Mumps - 23 Studies Found
| Active, not recruiting |
: Safety and Immunogenicity Study of Live Attenuated Mumps Vaccines in Healthy Infants : Mumps : 2016-02-23 :
|
| Not yet recruiting |
: Phase II of Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in Chinese Infants : Epidemic Parotitis,Mumps : 2017-04-17 :
|
| Completed |
: A Phase I, Safety Study of Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in Chinese Children : The Study Focused on the Safety of Attenuated Mumps Vaccine (Human Diploid Cell) Against Mumps in Chinese Adults, Children and Infants. : 2012-10-22 :
|
| Completed |
: Comparative Study of the Immunogenicity of MMR (Measles, Mumps and Rubella) Single Dose and Multidose Presentations :
: Biological: MMR Vaccine Administration of MMR Vaccine by Bio-Manguinhos or MMR Vaccine by GlaxoSmithKlin |
| Completed |
: Immunogenicity and Safety of GSK Biologicals' Combined Measles-mumps-rubella Vaccine in Volunteers, Seven Years of Age and Older :
: |
| Completed |
: Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of Age :
: |
| Completed |
: Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Children in Their Second Year of Life :
: |
| Completed |
: Serological Study in Children 12 to 23 Months Vaccinated With MMR (Measles, Mumps and Rubella) :
: Biological: MMR (Mumps, Measles and Rubella) MMR (Mumps, Measles and Rubella) |
| Completed |
: A Study of An Approved Vaccine at Mumps Expiry Potency in Healthy Children 12 to 18 Months of Age (V205C-007)(COMPLETED) :
: |
| Completed |
: Immunogenicity and Safety of Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases :
: Biological: Measles, Mumps, Rubella and Chickenpox (live vaccine) |